Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor

Journal of Neuroimmunology

Volumn 74, Issue 1-2, 1997, Pages 85-94

  Clements, John M ^a   Cossins, Judy A ^a   Wells, Graham M A ^a   Corkill, Dominic J ^b   Helfrich, Karen ^b   Wood, L Mike ^b   Pigott, Rod ^a   Stabler, Gary ^a   Ward, George A ^a   Gearing, Andrew J H ^a   Miller, Karen M ^a  

^a Neures Limited   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

central nervous system; experimental autoimmune encephalomyelitis; matrilysin; matrix metalloproteinase; metalloproteinase inhibitor; tumour necrosis factor

Indexed keywords

MATRILYSIN; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; ETIOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALS; DEXAMETHASONE; DRUG COMBINATIONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 7; METALLOENDOPEPTIDASES; PENTOXIFYLLINE; POLYMERASE CHAIN REACTION; PROTEASE INHIBITORS; RATS; RATS, INBRED LEW; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10744226623     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00210-X     Document Type: Article

References (44)

1. Alvord, E.G., Kiess, M.W. and Suckling, A.J. (1984) Experimental Allergic Encephalomyelitis: A Useful Model of Multiple Sclerosis. Alan R. Liss, New York.
2. Baker, D., Butler, D., Scallon, B.J., O'Neill, J.K., Turk, J.L. and Feldmann, M. (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
3. Baragi, V., Fliszar, C.J., Conroy, M.C., Ye, Q.-Z., Shipley, J.M. and Welgus, H.G. (1994) Contribution of the C-terminal truncated domain of metalloproteinases to binding by TIMP: C-terminal truncated stromelysin and matrilysin exhibit equally compromised affinities as compared to full-length stromelysin. J. Biol. Chem. 269, 12692-12697.
4. Benvenuto, R., Paroli. M., Buttinelli. C., Franco. A., Barnaba. V., Fieschi, C. and Balsano F. (1991) Tumour necrosis factor-alpha synthesis by cerebrospinal fluid-derived T-cell clones from patients with multiple sclerosis. Clin. Exp. Immunol. 84, 97-102.
5. Birkedal-Hansen, H., Moore, W.G.I., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J.A. (1993) Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med. 4, 197-250.
6. Black, R.A., Durie, F.H., Otten-Evans, C., Miller, R., Slack, J.L., Lynch, D.H., Castner, B., Mohler, K.M., Gerhart, M., Johnson, R.S., Itoh, Y., Okda, Y. and Nagase, H. (1996) Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophys. Res. Com. 225, 400-405.
7. Busiek, D.F., Baragi, V., Nehring, L.C., Parks, W.C. and Welgus, H.G. (1995) Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 154, 6484-6491.
8. Busiek, D.F., Ross, P.F., McDonnell, S., Murphy, G., Matrisian, L.M. and Welgus, H.G. (1992) The matrix metalloproteinase matrilysin (PUMP) is expressed in developing mononuclear phagocytes. J. Biol. Chem. 267, 9087-9092.
9. Cao, J., Sato, H., Takino, T. and Seiki, M. (1995) The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J. Biol. Chem. 270, 801-805.
10. 14C]acetylated collagen. Anal. Biochem. 99, 340-345.
11. Cawston, T.E., Galloway, W.A., Mercer, E., Murphy, G. and Reynolds, J.J. (1981) Purification of rabbit bone inhibitor of collagenase. Biochem. J. 195, 159-165.
12. Chandler, S., Coates, R., Gearing, A., Lury, J., Wells, G. and Bone, E. (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci. Lett. 201, 223-226.
13. Crowe, P.D., Walter, B.N., Mohler, K.M., Otten-Evans, C., Black, R.A. and Ware, C.F. (1995) A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T-lymphocytes. J. Exp. Med. 181, 1205-1210.
14. Conca, W. and Willmroth, F. (1994) Human T-lymphocytes express a member of the matrix metalloproteinase gene family. Arthritis Rheum. 37, 951-956.
15. Corkill, D.J., Woolley, K., Guard, S., Wright, Galloway, W.A, Thomas, S.W., Askew, M., Beckett, M.H., Davis, M.H., Miller, K., Stabler, G., Gearing, A. and Wood, L.M (1995) The effect of a novel inhibitor of tumour necrosis factor-a processing, BB-1101, in experimental autoimmune encephalomyelitis. Br. J. Pharmacol. (Suppl.) 116, 8P.
16. Cuzner, M.L, Davidson, A.N. and Rudge, P. (1978) Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis. Ann. Neurol. 4, 337-344.
17. DiStefano, P.S., Chelsea, D.M., Schick, C.M. and McKelvy, J.F. (1993) Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: Inhibition of truncation in vitro and in vivo. J. Neurosci. 13, 2405-2414.
18. Gearing, A.J.H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., Drummond, A.H., Galloway, W.H., Gilbert, R., Gordon, J.L., Leber, T.M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L.M. and Woolley, K. (1994) Processing of tumour necrosis factor-a precursor by metalloproteinases. Nature 370, 555-557.
19. Gijbels, K., Galardy, R.E. and Steinman, L. (1994) Reversal of autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177-2182.
20. Gijbels, K., Masure, S., Carton, H. and Opdenakker, G. (1992) Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41, 29-34.
21. Gijbels, K., Proost, P., Masure, S., Carton, H., Billiau, H. and Opdenakker, G. (1993) Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J. Neurosci. Res. 36, 432-440.
22. Gijbels, K. and Steinman, L. (1994) Gelatinase B producing cells in multiple sclerosis lesions. J. Biol. Chem. (Suppl.) 18D, 143.
23. Hallpike, J.F. and Adams, C.W.M. (1969) Proteolysis and myelin breakdown: A review of recent histochemical and biochemical studies. Histochem. J. 1, 559-578.
24. Hewson, A.K., Smith, T., Leonard, J.P. and Cuzner M.L. (1995) Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm. Res. 44, 345-349.
25. Inuzuka , T., Sato, S., Baba, H. and Miyatake, T. (1987) Neutral protease in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases. Acta Neurol. Scand. 76, 18-23.
26. Knight, C.G., Willenbrock, F. and Murphy, G. (1992) A novel coumarinlabelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296, 263-266.
27. Kuroda, Y. and Shimamoto, Y. (1991) Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34, 159-164.
28. Leppert, D., Waubant, E., Galardy, R., Bunnett, N.W. and Hauser, S.L. (1995) T-cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154, 4379-4389.
29. Megyeri, P., Abraham, C.S., Temesvari, P., Kovacs, J., Vas, T. and Speer, C.P. (1992) Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148, 137-140.
30. Mohler, K.M., Sleath, P.R., Fitzner, J.N., Cerretti, D.P., Alderson, M., Kerwar, S.S., Torrance, D.S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., Krohnheim, S.R., Petersen, M., Gerhart, M., Kozlosky, C.J., March, C.J. and Black, R.A. (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218-220.
31. Murphy, G., Cockett, M.I., Ward, R.V. and Docherty, A.J.P. (1991) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: A quantitative comparison of the activities of 95 kDa and 75 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277, 277-279.
32. Proost, P., Van Damme, J. and Opdenakker, G. (1993) Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun., 192, 1175-1181.
33. Romanic, A.M. and Madri, J.A. (1994) Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4, 145-156.
34. Rosenberg, G.A., Kornfeld, M., Estrada, E., Kelley, R.O., Liotta, L.A., and Stetler-Stevenson, W.G. (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase, Brain Res. 576, 203-207.
35. Rosenberg, G.A., Estrada, E.Y., Dencoff, J. and Stetler-Stevenson, W.G. (1995) Tumour necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window. Brain Res. 703, 151-155.
36. Sedgwick, J., Brostoff, S. and Mason, D. (1987) Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J. Exp. Med. 165, 1058-1075.
37. Selmaj, K., Raine, C.S., Cannella, B., and Brosnan, C.F. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
38. Sharief, M.K. and Thompson, E.J. (1992) In vivo relationship of tumour necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38, 27-34.
39. Shapiro, S.D., Kobayashi, D.K. and Ley, T.J. (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268, 23824-23829.
40. Sommer, N., Loschmann, R-A., Northhoff, G.H., Weller, M., Steinbrecher, A., Steinbach, J.P., Lichtenfels, R., Meyermann, R., Riethmuller, A., Fontana, A., Dichgans, J. and Martin, R. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1, 244-248.
41. Welgus, H.G., Campbell, E.J., Cury, J.D., Eisen, A.Z., Senior, R.M., Wilhelm, S.M. and Goldberg, G.J. (1990) Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation and expression during cellular development. J. Clin. Invest. 86, 1496-502.
42. Wells, G.M.A., Catlin, G., Cossins, J.A., Mangan, M., Ward, G.A., Miller, K.M. and Clements, J.M. (1996) Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 18, 332-340.
43. Yamada, T., Miyazaki, K., Seltzer, J.L., Schmid, T.M. and Jerrrey, J.J. (1995a) Selective localization of gelatinase A, an enzyme degrading β-amyloid protein, in white matter microglia and in Schwann cells. Acta Neuropathol. 89, 199-203.
44. Yamada, T., Yoshiyama, Y., Sato, H., Seiki, M., Shinagawa, A. and Takahashi, M. (1995b) White matter microglia produce membrane-type matrix metalloproteinase, an activator of gelatinase A, in human brain tissue. Acta Neuropathol. 90, 421-424.